Compounds > dd-13
Page last updated: 2024-11-07

dd-13

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-morpholinomethyl-tetrahydro-1(1H)-pyrimidinone: RN not in Chemline 12/85; RN from Toxline [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID134102
SCHEMBL ID5608494
MeSH IDM0136709

Synonyms (24)

Synonym
tetrahydro-1-(4-morpholinylmethyl)-2(1h)-pyrimidinone
dd-13
1-(4-morpholinomethyl)-tetrahydro-2(1h)-pyrimidinone
1-morpholinomethyl-tetrahydro-1(1h)-pyrimidinone
2(1h)-pyrimidinone, tetrahydro-1-(4-morpholinylmethyl)-
brn 6058057
mopyridone
dd 13
c9893zrm3k ,
unii-c9893zrm3k
82822-14-8
1-(morpholin-4-ylmethyl)-1,3-diazinan-2-one
UW75860000
2(1h)-pyrimidinone, tetrahydro-1-morpholinomethyl-
niosh/uw7586000
1-morpholinomethyltetrahydro-2(1h)-pyrimidinone
1-morpholinomethyl-tetrahydro-2(1h)-pyrimidinone
SCHEMBL5608494
dd13
1-(4-morpholinylmethyl)tetrahydro-2(1h)-pyrimidinone #
ZSWVOFMSMUXCLY-UHFFFAOYSA-N
Q27275348
1-[(morpholin-4-yl)methyl]-1,4,5,6-tetrahydropyrimidin-2-ol
DTXSID201002930

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The participation of some cytochrome P-450 isozymes, induced by MC and DEX, in biotransformation of MP to more toxic product(s) was suggested."( Toxicity and enzyme-inducing effect of the antiviral compound mopyridone in mice.
Rangelova, DS; Tantcheva, LP, 1996)		0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.00 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index68.71 (26.88)
Search Engine Supply Index2.02 (0.95)

This Compound (48.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
hexobarbital
Hexobarbital: A barbiturate that is effective as a hypnotic and sedative.. hexobarbital : A member of the class of barbiturates taht is barbituric acid substituted at N-1 by methyl and at C-5 by methyl and cyclohex-1-enyl groups.		1.9810barbiturates
rimantadine
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.		1.9810alkylamine
octyl glucoside
octyl-beta-D-glucoside: RN given refers to (beta)-isomer. octyl beta-D-glucopyranoside : An beta-D-glucoside in which the anomeric hydrogen of beta-D-glucopyranose is substituted by an octyl group.		1.9810beta-D-glucosideplant metabolite
glucose, (beta-d)-isomer
beta-D-glucose : D-Glucopyranose with beta configuration at the anomeric centre.. (1->4)-beta-D-glucan : A beta-D-glucan in which the glucose units are connected by (1->4) linkages.. (1->3)-beta-D-glucan : A beta-D-glucan in which the glucose units are connected by (1->3) linkages.		1.9810D-glucopyranoseepitope;
mouse metabolite
pyrimidinones
Pyrimidinones: Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O.		3.0850
ConditionIndicatedRelationship StrengthStudiesTrials
Extravascular Hemolysis
[description not available]		01.9810
Hemolysis
The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.		01.9810
Infections, Togaviridae
[description not available]		01.9610